Vimarsana
Biggest News Aggregation in the World

Page 34 - Jeff Wolf News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jeff Wolf. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jeff Wolf Today - Breaking & Trending Today

Glioblastoma Multiforme (GBM) Treatments Advancing as FDA Steps Up Measures Due to Rising Incidences - Vimarsana News

Glioblastoma Multiforme (GBM) Treatments Advancing as FDA Steps Up Measures Due to Rising Incidences

Glioblastoma Multiforme (GBM) Treatments Advancing as FDA Steps Up Measures Due to Rising Incidences PALM BEACH, Fla., Dec. 17, 2020 /PRNewswire/ -- Glioblastoma multiforme (GBM) is the most common and aggressive malignant brain tumor in humans that involves glial cells. GBM is present in two variants namely, giant cell glioblastoma and gliosarcoma. Gliomas are tumors arising from glial cells and may occur in the spinal cord or the brain, the latter being more common. Gliomas are the most common type of brain tumor and can be either supratentorial or infratentorial. Seizure, nausea, headache...

Heat Biologics, Inc.: Heat Biologics Announces Completion of ZVX-60 Vaccine Cell Line for COVID-19 - Vimarsana News

Heat Biologics, Inc.: Heat Biologics Announces Completion of ZVX-60 Vaccine Cell Line for COVID-19

Heat Biologics, Inc.: Heat Biologics Announces Completion of ZVX-60 Vaccine Cell Line for COVID-19 Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product candidates and a novel COVID-19 vaccine, today announces it has completed its gp96-based COVID-19 vaccine cell line ("ZVX-60"), which is being developed for use as either a standalone vaccine, or in combination with other vaccines to enhance prophylactic protection. Data, generated at the Universi...